Dr. Doms is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1989 - 1992
- Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1988 - 1989
- Yale School of MedicineClass of 1988
Certifications & Licensure
- PA State Medical License 1991 - 2024
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1997
Publications & Presentations
PubMed
- 1555 citationsA dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.Benjamin J. Doranz, Joseph Rucker, Yanjie Yi, Robert J. Smyth, Michel Samson
Cell. 1996-06-28 - 75 citationsCell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.Joseph Rucker, Benjamin J. Doranz, Aimee L. Edinger, Deborah Long, Joanne F. Berson
Methods in Enzymology. 1997-01-01 - 174 citationsTwo distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.Benjamin J. Doranz, Z H Lu, Joseph Rucker, Tian-yuan Zhang, Matthew Sharron
Journal of Virology. 1997-09-01
Press Mentions
- Antigenicity, Stability, and Reproducibility of Zika Reporter Virus Particles for Long-Term ApplicationsNovember 18th, 2020
- CD Genomics Introduces HLA Typing by Next-Generation Sequencing to Its Global R&D ClientsJune 26th, 2018
Grant Support
- Interactions Of Emerging Bunyaviruses With Host CellsNational Institute Of Allergy And Infectious Diseases2009–2012
- Finger Nucleases To Specifically Disrupt Coreceptor ExpressionNational Institute Of Allergy And Infectious Diseases2009–2012
- Training In Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2003–2011
- Training In HIV PathogenesisNational Institute Of Allergy And Infectious Diseases2000–2011
- HIV Entry And Its InhibitionNational Institute Of Allergy And Infectious Diseases2006–2010
- Crimean Congo Hemorrhagic Fever Virus GlycoproteinsNational Institute Of Allergy And Infectious Diseases2005–2006
- Acquired Immunodeficiency Syndrome ReviewNational Institute Of Allergy And Infectious Diseases2004–2005
- Interactions Between HIV And SIV With DC-SIGN &Dc-SignrNational Institute Of Allergy And Infectious Diseases2001–2005
- Chemokine Receptors And HIV And SIV InfectionNational Institute Of Allergy And Infectious Diseases1997–2005
- HIV-1 And HIV-2 Infection Of Non-Dividing CellsNational Institute Of Allergy And Infectious Diseases2003
- Biosynthesis And Processing Of AB In NT2N CellsNational Institute On Aging1998–2002
- Immunization And Humoral Response To HIV1 896 ENVNational Institute Of Allergy And Infectious Diseases1998–2002
- Biosynthesis And Processing Of Beta-Amyloid Precursor Protein In NT2N CellsNational Institute On Aging1996–1997
- Neutralizing Antibodies Specific For Oligomeric HIV1 ENVNational Institute Of Allergy And Infectious Diseases1994–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: